What you need to know about the Johnson & Johnson coronavirus vaccine headed toward approval

Published



A panel of vaccine advisers at the Food and Drug Administration will meet Friday to discuss whether the agency should grant emergency use authorization to the COVID-19 vaccine developed by Johnson & Johnson-owned Janssen Pharmaceuticals. Here are the answers to the most pressing questions.

How efficacious is the vaccine?

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.